FDA approves a generic version of the drug Martin Shkreli monopolized
DREW ANGERER/GETTY IMAGES
The approval means Shkreli's company, once called Turing and now known as Phoenixus, will no longer have a monopoly on Daraprim.
Suscribirse a:
Enviar comentarios (Atom)
.png)
No hay comentarios:
Publicar un comentario